Hawaii Pacific Neuroscience · Centers

ALS & Neuromuscular Center

In her own words

Our vision for neuromuscular care in Hawaii

I am thrilled to lead the first of its kind Neuromuscular program in Hawaii and the Pacific Regions, with a special focus on autoimmune neuromuscular disorders. This vision is driven by the critical need for specialized expertise in diagnosing and treating neuromuscular disorders, particularly in underserved areas where access to advanced care is limited. My vision is to create a center of excellence that serves patients with neuromuscular disorders especially related to immune system.

With the development of new therapeutic targets and approval of new medications to treat these disorders, this field is rapidly evolving and gaining complexity. Thus, I plan to leverage the expertise gained during my dual fellowship in neuromuscular and neuroimmunology to tackle this. The development of a multidisciplinary team will be key with physical therapists, occupational therapists, speech therapists, and social workers to build a strong and comprehensive care network for our patients. This team will ensure that our patients receive not only top-notch medical care but also holistic support for their physical and emotional well-being.

My commitment to research and clinical trials to expand the horizons of available treatments and enhance the quality of care we provide. The ultimate goal is to become a trusted resource for patients who may otherwise have limited options for managing their neuromuscular conditions. I would empower our patients through conferences and QA panel discussions, actively collaborate with local & national organizations to raise awareness and empower individuals to take control of their conditions.

My vision is to create a Neuromuscular Center in Hawaii that embodies equity, compassion, and innovation to make a lasting impact on their lives.

Natalia Gonzalez Caldito, M.D.

Director, ALS & Neuromuscular Center (MGFA Center, ALS Center, MDA Center),

Director, Infusion Center 

Sub investigator, Neuromuscular Research Unit

Neuromuscular Fellowship: University of California School of Medicine, Irvine

Neuroimmunology Fellowship: Northwestern University, Chicago

Neurology Residency: University Texas Southwestern, Dallas

Patients, families & caregivers

You are not alone in this journey

Our specialists and staff are passionate about making a difference not just for our patients but for their precious families and caregivers. We understand the challenges of facing these issues and want to be sure you do not feel alone in this journey.

We encourage you to contact the local resources available to you, and to reach out to our team whenever you need guidance between visits.

Updates

Latest from ALS & Neuromuscular Center

Hawaii Pacific Neuroscience Physicians Named 2026 Castle Connolly Top Doctors

Hawaii Pacific Neuroscience Physicians Named 2026 Castle Connolly Top Doctors

Recognition & Excellence Hawaii Pacific Neuroscience Physicians Named 2026 Castle Connolly Top Doctors Four specialists at Hawaii Pacific Neuroscience — along with the center itself — have earned a place among the nation’s most recognized physicians and practices, with Castle Connolly designating them 2026 Top Doctors. Nicholas Anderson, MD; Darren Dugas, MD; Natalia Gonzalez, MD; […]

Hawaii Selected to Investigate Povetacicept for Myasthenia Gravis

Neuromuscular Research · Clinical Trial Update Hawaii ALS & Neuromuscular Center Selected to Investigate Povetacicept in Generalized Myasthenia Gravis A milestone for Hawaii patients, caregivers, and the neuromuscular research community The Hawaii ALS & Neuromuscular Center team — bringing world-class neuromuscular research to the Pacific. The Hawaii ALS and Neuromuscular Center and the Neuromuscular Research […]

Hawaii ALS and Neuromuscular Center Selected for ADAPT-EARLY Clinical Trial in Generalized Myasthenia Gravis (gMG)

The Hawaii ALS and Neuromuscular Center has been selected to participate in the ADAPT-EARLY clinical trial, a Phase 4 research study evaluating efgartigimod PH20 SC in adults with new-onset generalized myasthenia gravis (gMG). This important study focuses on early treatment intervention for individuals diagnosed with gMG within the past year  . What Is Generalized Myasthenia […]

Call us or text us

Locations in Honolulu and West Oahu. We are available Monday to Friday, 8:00 am to 5:00 pm, with phones off from 12:30–1:30 pm. Leave a message and we will get back to you within 24–48 business hours.

©2026, Hawaii Pacific Neuroscience. All Rights Reserved.